Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Expert Opin Emerg Drugs. 2011 Mar 22;16(3):407–423. doi: 10.1517/14728214.2011.568938

Figure 1. Kinase selectivity of FLT3 inhibitors.

Figure 1

This kinase dendogram was adapted and is reproduced with permission from the American Society of Hematology [97].

FLT3: FMS-like tyrosine kinase 3.